China Approves Amgen’s Tarlatamab (Imdelltra) for Advanced Small Cell Lung Cancer
Shanghai: Amgen's lung cancer drug tarlatamab has won approval from ​China's National Medical Products Administration, its development and commercialisation partner BeOne Medicines said on Friday on WeChat.The drug ​is a…